Ebit Veränderung Datum
Adma Biologics USD 53.66M 5.57M 2026-06
Agenus USD 15.05M 656K 2026-03
AstraZeneca USD 4.66B 1.5B 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Cassava Sciences USD -9.39M 1.78M 2026-06
Geron USD 5.73M 15.26M 2026-09
GlaxoSmithKline GBP 2.86B 251M 2026-09
MannKind USD -59.44M 8.79M 2026-09
Merck USD 7.33B 6.49B 2026-09
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Moderna USD 130M 945M 2026-09
Novartis USD 1.78B 2.4B 2026-09
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.85B 5.03B 2026-09
Sanofi EUR 4.72B 3.6B 2026-09
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
TG Therapeutics USD 85.9M 64.22M 2026-09